S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
S&P 500   4,356.45 (-1.22%)
DOW   34,297.73 (-0.19%)
QQQ   345.11 (-2.32%)
AAPL   159.78 (-1.14%)
MSFT   288.49 (-2.66%)
FB   300.15 (-2.77%)
GOOGL   2,538.70 (-2.96%)
AMZN   2,799.72 (-3.15%)
TSLA   918.40 (-1.25%)
NVDA   223.24 (-4.48%)
BABA   119.14 (-1.02%)
NIO   23.79 (-4.34%)
AMD   111.13 (-4.63%)
CGC   7.36 (-0.54%)
MU   80.72 (-2.69%)
GE   91.11 (-5.98%)
T   26.48 (+0.53%)
F   19.98 (-2.01%)
DIS   136.51 (-0.69%)
AMC   16.02 (-3.73%)
PFE   52.54 (+1.94%)
ACB   4.21 (-2.55%)
BA   204.10 (-0.05%)
NASDAQ:ENTA

Enanta Pharmaceuticals Insider Trades

$58.59
+0.18 (+0.31%)
(As of 01/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$56.63
$59.98
50-Day Range
$56.49
$92.58
52-Week Range
$40.37
$102.00
Volume
199,792 shs
Average Volume
216,850 shs
Market Capitalization
$1.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.53

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.74%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
2

Amount Of
Insider Selling
(Last 12 Months)
$4.35 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ENTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Enanta Pharmaceuticals (NASDAQ ENTA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/11/2022Nathalie AddaVPSell12,536$70.13$879,149.68  
12/1/2021Nathalie AddaVPSell13,523$86.35$1,167,711.05  
11/1/2021Nathalie AddaVPSell9,547$84.89$810,444.83  
10/11/2021Nathalie AddaVPSell4,047$70.34$284,665.98  
10/8/2021Nathalie AddaVPSell13,453$70.09$942,920.77  
9/15/2021Jay R LulyCEOSell4,516$59.06$266,714.96  
1/8/2021Paul J MellettCFOSell6,000$45.58$273,480.0061,759  
1/2/2020Paul J. MellettCFOSell10,000$60.88$608,800.00  
3/11/2019Bruce L A CarterDirectorSell1,546$99.16$153,301.361,546  
3/4/2019George GolumbeskiDirectorSell9,280$103.65$961,872.009,280  
3/1/2019Yat Sun OrVPSell10,000$103.53$1,035,300.00304,763  
2/13/2019Nathaniel S GardinerVPSell3,270$95.28$311,565.60320,169  
2/12/2019Bruce L A CarterDirectorSell7,734$90.01$696,137.342,734  
2/11/2019Yat Sun OrVPSell27,684$89.39$2,474,672.76320,169  
10/1/2018Tim OcainInsiderSell25,000$83.64$2,091,000.00  
9/20/2018Nathalie AddaVPSell4,155$95.32$396,054.604,155  
8/20/2018Nathalie AddaVPSell4,155$92.32$383,589.604,465  
7/18/2018Nathalie AddaVPSell5,045$124.84$629,817.806,555  
7/6/2018Jay R LulyInsiderSell35,000$125.24$4,383,400.00625,049  
6/18/2018Nathalie AddaVPSell4,155$114.85$477,201.757,755  
6/11/2018Paul J MellettTreasurerSell15,000$120.57$1,808,550.0088,158  
5/17/2018Jay R LulyInsiderSell25,000$105.83$2,645,750.00638,994  
5/16/2018Nathalie AddaVPSell4,155$105.25$437,313.758,955  
4/16/2018Nathalie AddaVPSell4,225$85.58$361,575.5010,225  
3/19/2018Paul J MellettTreasurerSell9,000$86.48$778,320.0096,458  
1/4/2017Yat Sun OrInsiderSell13,921$35.09$488,487.89301,876  
11/29/2016Yat Sun OrInsiderSell13,921$31.44$437,676.24315,797  
5/11/2016Nathaniel S GardinerVPBuy500$24.45$12,225.001,900  
2/12/2016Terry VanceDirectorBuy2,000$27.04$54,080.0015,295  
11/24/2015Paul J. MellettCFOSell6,000$30.15$180,900.0054,397  
10/15/2015Paul J MellettCFOSell7,500$40.10$300,750.0060,397  
9/8/2015Paul J. MellettCFOSell7,500$39.55$296,625.0067,897  
7/13/2015Paul J MellettCFOSell7,500$46.29$347,175.00  
7/13/2015Yat Sun OrInsiderSell3,750$46.29$173,587.50  
6/11/2015Paul J MellettCFOSell7,500$42.51$318,825.00  
6/11/2015Yat Sun OrInsiderSell3,750$42.47$159,262.50  
6/5/2015Yat Sun OrInsiderSell10,750$42.02$451,715.00  
5/19/2015Paul J MellettCFOSell24,000$40.13$963,120.00  
5/11/2015Yat Sun OrInsiderSell8,000$36.13$289,040.00  
3/9/2015Jay R LulyCEOSell15,000$33.37$500,550.00  
2/20/2015Jay R LulyCEOSell15,000$35.35$530,250.00  
2/19/2015Stephen Jr. BuckleyDirectorBuy1,000$34.00$34,000.00  
2/17/2015Nathaniel S GardinerVPBuy1,400$33.23$46,522.00  
1/16/2015Paul J MellettCFOSell4,500$49.45$222,525.00  
1/5/2015Jay R LulyCEOSell15,000$50.43$756,450.00  
12/1/2014Jay R LulyCEOSell15,000$45.39$680,850.00  
11/3/2014Jay R LulyCEOSell15,000$42.52$637,800.00  
9/15/2014Paul J MellettCFOSell10,000$39.83$398,300.00  
8/14/2014Paul J MellettCFOSell10,000$39.13$391,300.00  
8/14/2014Stephen Jr. BuckleyDirectorBuy1,000$38.95$38,950.00  
7/14/2014Paul J MellettCFOSell20,000$39.88$797,600.00  
5/1/2014Yat Sun OrInsiderSell5,000$36.98$184,900.00184,078  
4/1/2014Jay LulyCEOSell15,000$39.17$587,550.00544,338  
4/1/2014Yat Sun OrInsiderSell10,000$39.16$391,600.00189,078  
3/24/2014Yat Sun OrInsiderSell10,000$39.34$393,400.00199,078  
3/4/2014V Life Science Ventures Gm Tvmmajor shareholderSell439,334$38.82$17,054,945.88  
2/26/2014V Life Science Ventures Gm Tvmmajor shareholderSell230,190$39.15$9,011,938.50  
2/24/2014V Life Science Ventures Gm Tvmmajor shareholderSell60,477$39.57$2,393,074.89  
2/14/2014Jay LulyCEOSell5,800$38.10$220,980.00569,338  
1/2/2014Jay R LulyCEOSell5,800$28.05$162,690.00  
12/6/2013Marc E GoldbergDirectorSell6,861$27.93$191,627.73  
10/14/2013Saints Capital Granite, L.P.Major ShareholderSell32,301$19.84$640,851.84  
10/10/2013Saints Capital Granite, L.P.Major ShareholderSell36,207$21.71$786,053.97  
10/3/2013Saints Capital Granite, L.P.Major ShareholderSell12,300$23.39$287,697.00  
3/26/2013Helmut SchuhslerDirectorBuy132,949$14.00$1,861,286.00  
3/26/2013Saints Capital Granite, L.P.Major ShareholderBuy66,474$14.00$930,636.00  
(Data available from 1/1/2013 forward)












Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Trade Frequently Asked Questions

Who is on Enanta Pharmaceuticals's Insider Roster?

The list of insiders at Enanta Pharmaceuticals includes Bruce L A Carter, George Golumbeski, Jay R Luly, Nathalie Adda, Nathaniel S Gardiner, Paul J Mellett, and Yat Sun Or.Learn more on ENTA's insiders

What percentage of Enanta Pharmaceuticals stock is owned by insiders?

11.74% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings

Which Enanta Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Enanta Pharmaceuticals stock in the last 24 months: Jay R Luly ($266,714.96), Nathalie Adda ($4,084,892.31), and Paul J Mellett ($273,480.00).

How much insider selling is happening at Enanta Pharmaceuticals?

Insiders have sold a total of 63,622 Enanta Pharmaceuticals shares in the last 24 months for a total of $4,625,087.27 sold.

This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.